共 50 条
- [21] Pembrolizumab in the treatment of locally advanced or metastatic urothelial carcinoma: clinical trial evidence and experienceTHERAPEUTIC ADVANCES IN UROLOGY, 2019, 11 : 1 - 9Crist, MichaelIyer, GopaHsu, MilesHuang, William C.Balar, Arjun, V
- [22] Patient-Reported Outcomes in Prospective Cohort of Patients with Borderline Resectable or Locally Advanced Pancreatic Cancer Undergoing RadiotherapyINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E628 - E628Thunshelle, C. P.Kouzy, R.Jaoude, J. AbiChowdhury, T.Zaid, M.Mathew, R.Prakash, L.Katz, M. H. G.Minsky, B. D.Holliday, E., Jr.Das, P.Smith, G. L.Herman, J. M.Koong, A. C.Taniguchi, C. M.Wang, X. S.Koay, E. J.
- [23] Obesity and Breast Reconstruction: Complications and Patient-Reported Outcomes in a Multicenter, Prospective StudyPLASTIC AND RECONSTRUCTIVE SURGERY, 2020, 145 (03) : 481E - 490ESrinivasa, Dhivya R.Clemens, Mark W.Qi, JiHamill, Jennifer B.Kim, Hyungjin M.Pusic, Andrea L.Wilkins, Edwin G.Butler, Charles E.Garvey, Patrick B.
- [24] Preliminary results of perioperative patient-reported outcomes in patients with lung cancer: a multicenter observational cohort studyQUALITY OF LIFE RESEARCH, 2020, 29 (SUPPL 1) : S93 - S94Dai, WeiWei, XingWang, YaqinLiao, JiaLiu, FangFeng, YaqianXu, WeiYu, HongfanYu, QingsongPu, YangYang, XiaojunLi, QiangShi, Qiuling
- [25] Correlation of inflammatory biomarkers and patient-reported outcomes in patients with urothelial carcinoma treated with durvalumabJOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5Degboe, ArnoldSridhar, SrikalaZhang, JingsongMukhopadhyay, PralayGupta, AshokRoskos, LorinGuo, XiangFriedlander, Terence
- [26] Impact of antacids on the prognosis of patients with metastatic urothelial carcinoma treated with pembrolizumab: A retrospective multicenter studyEUROPEAN UROLOGY, 2024, 85 : S1734 - S1735Sekito, T.Katayama, S.Iwata, T.Kawada, T.Tominaga, Y.Sadahira, T.Nishimura, S.Bekku, K.Edamura, K.Kobayashi, T.Kobayashi, Y.Araki, M.
- [27] Patient-reported outcomes in KEYNOTE-006, a randomised study of pembrolizumab versus ipilimumab in patients with advanced melanomaEUROPEAN JOURNAL OF CANCER, 2017, 86 : 115 - 124Petrella, Teresa M.Robert, CarolineRichtig, ErikaMiller, Wilson H., Jr.Masucci, Giuseppe V.Walpole, EuanLebbe, CelesteSteven, NeilMiddleton, Mark R.Hille, DarcyZhou, WeiIbrahim, NageatteCebon, Jonathan
- [28] ONCOLOGICAL OUTCOMES OF NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED UPPER TRACT UROTHELIAL CARCINOMA: A MULTICENTER RETROSPECTIVE STUDYJOURNAL OF UROLOGY, 2021, 206 : E865 - E865Kubota, YukaHatakeyama, ShingoOkamoto, TeppeiYamamoto, HayatoYoneyama, TakahiroHashimoto, YasuhiroOhyama, Chikara
- [29] Patients' self-management of adverse events and patient-reported outcomes in advanced renal cell carcinoma treated with targeted therapies: A prospective, longitudinal, observational studyJOURNAL OF PATIENT-REPORTED OUTCOMES, 2022, 6 (01)Hong, Sung-HooChung, Ho SeokSeo, Ill-YoungKwon, Tae GyunJeong, HyeonChung, Jae-IlJeon, Seung HyunPark, Jae YoungHa, Hong KooChung, Byung-HaSong, WanKim, Young-JooKim, Sang-HeeLee, Jee-SunLee, JuneyoungChung, Jinsoo
- [30] Patients’ self-management of adverse events and patient-reported outcomes in advanced renal cell carcinoma treated with targeted therapies: A prospective, longitudinal, observational studyJournal of Patient-Reported Outcomes, 6Sung-Hoo HongHo Seok ChungIll-Young SeoTae Gyun KwonHyeon JeongJae-Il ChungSeung Hyun JeonJae Young ParkHong Koo HaByung-Ha ChungWan SongYoung-Joo KimSang-Hee KimJee-Sun LeeJuneyoung LeeJinsoo Chung